BioGraph 55
Developer of novel B-cell therapies and drugs designed to address significant unmet clinical needs of autoimmunity. The company offers discovering and developing bispecific antibodies for immuno-oncol...
Valuation
$25M
Latest known
Share Price
N/A
Total Raised
$20.1M
Last Round
N/A